407 related articles for article (PubMed ID: 15838723)
1. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
Yuen NS; Cheung P; Hui SP
Jpn J Ophthalmol; 2005; 49(2):89-92. PubMed ID: 15838723
[TBL] [Abstract][Full Text] [Related]
2. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
Chevrier RL; Assalian A; Duperré J; Lesk MR
Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
[TBL] [Abstract][Full Text] [Related]
3. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
Chen TC
J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
[TBL] [Abstract][Full Text] [Related]
4. Control of intraocular pressure elevations after argon laser trabeculoplasty: comparison of brimonidine 0.2% to apraclonidine 1.0%.
Barnes SD; Campagna JA; Dirks MS; Doe EA
Ophthalmology; 1999 Oct; 106(10):2033-7. PubMed ID: 10519604
[TBL] [Abstract][Full Text] [Related]
5. The rarity of clinically significant rise in intraocular pressure after laser peripheral iridotomy with apraclonidine.
Lewis R; Perkins TW; Gangnon R; Kaufman PL; Heatley GA
Ophthalmology; 1998 Dec; 105(12):2256-9. PubMed ID: 9855156
[TBL] [Abstract][Full Text] [Related]
6. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
[TBL] [Abstract][Full Text] [Related]
7. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
Nishimoto JH; Chang FW; Tang IH; Kolin T
J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
[TBL] [Abstract][Full Text] [Related]
8. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
Threlkeld AB; Assalian AA; Allingham RR; Shields MB
Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
[TBL] [Abstract][Full Text] [Related]
9. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of early phacoemulsification versus peripheral iridotomy to prevent intraocular pressure rise after acute primary angle closure.
Lam DS; Leung DY; Tham CC; Li FC; Kwong YY; Chiu TY; Fan DS
Ophthalmology; 2008 Jul; 115(7):1134-40. PubMed ID: 18164064
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C
Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical brinzolamide 1% and brimonidine 0.2% on intraocular pressure after phacoemulsification.
Cetinkaya A; Akman A; Akova YA
J Cataract Refract Surg; 2004 Aug; 30(8):1736-41. PubMed ID: 15313300
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the short-term hypotensive effects and side effects of unilateral brimonidine and apraclonidine in patients with elevated intraocular pressure.
Yüksel N; Karabaş L; Altintaş O; Yildirim Y; Cağlar Y
Ophthalmologica; 2002; 216(1):45-9. PubMed ID: 11901288
[TBL] [Abstract][Full Text] [Related]
14. [Apraclonidine prevents the acute increase of intraocular pressure in brown eyes with Nd:YAG laser iridectomy].
Zhao J; Mao J; Liu X
Zhonghua Yan Ke Za Zhi; 1998 May; 34(3):170-3. PubMed ID: 11877181
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
16. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
[TBL] [Abstract][Full Text] [Related]
17. Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.
Gabelt BT; Robinson JC; Hubbard WC; Peterson CM; Debink N; Wadhwa A; Kaufman PL
Exp Eye Res; 1994 Dec; 59(6):633-44. PubMed ID: 7698258
[TBL] [Abstract][Full Text] [Related]
18. The effect of 1% apraclonidine on intraocular pressure after cataract surgery.
Sterk CC; Renzenbrink-Bubberman AC; van Best JA
Ophthalmic Surg Lasers; 1998 Jun; 29(6):472-5. PubMed ID: 9640568
[TBL] [Abstract][Full Text] [Related]
19. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
Miller PE; Nelson MJ; Rhaesa SL
Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
[TBL] [Abstract][Full Text] [Related]
20. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise.
Rosenberg LF; Krupin T; Ruderman J; McDaniel DL; Siegfried C; Karalekas DP; Grewal RK; Gieser DK; Williams R
Ophthalmology; 1995 Sep; 102(9):1312-8. PubMed ID: 9097768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]